BOLGER JOHN C 4
4 · Fulgent Genetics, Inc. · Filed Sep 1, 2021
Insider Transaction Report
Form 4
BOLGER JOHN C
Director
Transactions
- Exercise/Conversion
Common Stock
2021-08-30$3.92/sh+312$1,225→ 2,312 total - Sale
Common Stock
2021-08-30$91.38/sh−312$28,511→ 2,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-08-30−312→ 938 totalExercise: $3.92Exp: 2028-05-18→ Common Stock (312 underlying)
Footnotes (3)
- [F1]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
- [F2]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
- [F3]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.